微生物蛋白业务取得关键性突破 富祥药业未冉蛋白国内获批上市

Core Points - The National Health Commission of China has approved the safety assessment of Venetian scythe fungus protein as a new food ingredient, allowing its production and sale domestically, which will accelerate the commercialization of the product by the company [1] - The approval supports national food security and aims to meet the growing demand for high-quality protein in China [1] Company Summary - Fujian Bio has obtained certifications for its Venetian scythe fungus protein from regulatory bodies in China, the United States, Singapore, and Europe, establishing a solid foundation for global commercial application [2] - The protein is high in content, containing 18 essential amino acids, dietary fiber, and minerals such as calcium, zinc, and iron, while ensuring zero antibiotics, pesticide residues, and hormones [2] - The company has developed two product forms: dry and wet, targeting applications in various sectors including plant-based meat, protein beverages, baked goods, dairy alternatives, health foods, special medical foods, and pet foods [2] - Fujian Bio aims to build an internationally competitive full industry chain for the fungus protein, currently having an annual production capacity of 1,200 tons and is accelerating the construction of a project with a capacity of 20,000 tons per year [2] - Upon completion, the project will produce 20,000 tons of microbial protein and 50,000 tons of amino acid water-soluble fertilizer, positioning the company to potentially lead the industry in production capacity [2]